Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Empowerment of patients in online discussions about medicine use.

van Berkel JJ, Lambooij MS, Hegger I.

BMC Med Inform Decis Mak. 2015 Apr 8;15:24. doi: 10.1186/s12911-015-0146-6.

2.

Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.

Meyer N, Dallinga JW, Nuss SJ, Moonen EJ, van Berkel JJ, Akdis C, van Schooten FJ, Menz G.

Respir Res. 2014 Nov 28;15:136. doi: 10.1186/s12931-014-0136-8.

3.

Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry.

Boots AW, Smolinska A, van Berkel JJ, Fijten RR, Stobberingh EE, Boumans ML, Moonen EJ, Wouters EF, Dallinga JW, Van Schooten FJ.

J Breath Res. 2014 Jun;8(2):027106. doi: 10.1088/1752-7155/8/2/027106. Epub 2014 Apr 16.

PMID:
24737039
4.

Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study.

Robroeks CM, van Berkel JJ, Jöbsis Q, van Schooten FJ, Dallinga JW, Wouters EF, Dompeling E.

Eur Respir J. 2013 Jul;42(1):98-106. doi: 10.1183/09031936.00010712. Epub 2013 May 3.

5.

Exhaled breath profiling in diagnosing wheezy preschool children.

van de Kant KD, van Berkel JJ, Jöbsis Q, Lima Passos V, Klaassen EM, van der Sande L, van Schayck OC, de Jongste JC, van Schooten FJ, Derks E, Dompeling E, Dallinga JW.

Eur Respir J. 2013 Jan;41(1):183-8. doi: 10.1183/09031936.00122411.

6.

The versatile use of exhaled volatile organic compounds in human health and disease.

Boots AW, van Berkel JJ, Dallinga JW, Smolinska A, Wouters EF, van Schooten FJ.

J Breath Res. 2012 Jun;6(2):027108. doi: 10.1088/1752-7155/6/2/027108. Epub 2012 May 23. Review.

PMID:
22621865
7.

Breath analysis as a potential diagnostic tool for tuberculosis.

Kolk AH, van Berkel JJ, Claassens MM, Walters E, Kuijper S, Dallinga JW, van Schooten FJ.

Int J Tuberc Lung Dis. 2012 Jun;16(6):777-82. doi: 10.5588/ijtld.11.0576. Epub 2012 Apr 9.

PMID:
22507235
8.

Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.

Robroeks CM, van Berkel JJ, Dallinga JW, Jöbsis Q, Zimmermann LJ, Hendriks HJ, Wouters MF, van der Grinten CP, van de Kant KD, van Schooten FJ, Dompeling E.

Pediatr Res. 2010 Jul;68(1):75-80. doi: 10.1203/00006450-201011001-00143.

PMID:
20351658
9.

A profile of volatile organic compounds in breath discriminates COPD patients from controls.

Van Berkel JJ, Dallinga JW, Möller GM, Godschalk RW, Moonen EJ, Wouters EF, Van Schooten FJ.

Respir Med. 2010 Apr;104(4):557-63. doi: 10.1016/j.rmed.2009.10.018. Epub 2009 Nov 10.

10.

Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children.

Dallinga JW, Robroeks CM, van Berkel JJ, Moonen EJ, Godschalk RW, Jöbsis Q, Dompeling E, Wouters EF, van Schooten FJ.

Clin Exp Allergy. 2010 Jan;40(1):68-76. doi: 10.1111/j.1365-2222.2009.03343.x. Epub 2009 Sep 28.

PMID:
19793086
11.

Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air.

Van Berkel JJ, Dallinga JW, Möller GM, Godschalk RW, Moonen E, Wouters EF, Van Schooten FJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jan 1;861(1):101-7. Epub 2007 Nov 19.

PMID:
18055279

Supplemental Content

Loading ...
Support Center